Maynard Um
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Beam Therapeutics Inc (BEAM)
-
-
-
-
-
-
-
RBC on Beam Therapeutics Inc (BEAM): 'we view the data as incrementally positive'
-
-
-
-
-
-
-
Beam Therapeutics (BEAM) Reiterated at Overweight by Cantor Fitzgerald
-
-
-
-
-
-
-
FDA Clears Way for Faster Personalized Gene Editing Treatments
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Beam Therapeutics Inc (BEAM)
-
-
-
-
-
-
-
Beam (BEAM) Announces U.S. FDA RMAT Designation Granted to BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency
-
-
-
-
-
-
-
Bernstein SocGen Group Reiterates Outperform Rating on Beam Therapeutics Inc (BEAM)
-
431,140 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

